Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Jul 24 2024

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-jul-24-2024-14

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated July 24, 2024, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases